Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,948 | 271 | 53.8% |
| Travel and Lodging | $1,869 | 7 | 25.5% |
| Education | $1,520 | 2 | 20.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $3,386 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $859.76 | 75 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $545.23 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $438.71 | 20 | $0 (2024) |
| Genentech USA, Inc. | $282.22 | 21 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $197.38 | 16 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $154.82 | 9 | $0 (2024) |
| Chiesi USA, Inc. | $145.36 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $133.98 | 9 | $0 (2019) |
| Grifols USA, LLC | $106.38 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,869 | 36 | INTUITIVE SURGICAL, INC. ($3,386) |
| 2023 | $211.62 | 12 | Genentech USA, Inc. ($31.81) |
| 2022 | $136.83 | 7 | ABBVIE INC. ($37.19) |
| 2021 | $116.02 | 1 | Chiesi USA, Inc. ($116.02) |
| 2020 | $123.12 | 10 | GlaxoSmithKline, LLC. ($46.19) |
| 2019 | $1,149 | 79 | GlaxoSmithKline, LLC. ($283.37) |
| 2018 | $1,062 | 81 | GlaxoSmithKline, LLC. ($321.88) |
| 2017 | $669.23 | 54 | GlaxoSmithKline, LLC. ($195.11) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.69 | General |
| 12/11/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/26/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Immunology and Neurology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Pulmonology | ||||||
| 09/17/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Insomnia | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Respiratory | ||||||
| 06/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 05/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/30/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Respiratory | ||||||
| 04/02/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/22/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Immunology | ||||||
| 02/16/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Respiratory | ||||||
| 02/05/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $121.00 | General |
| Category: SURGERY | ||||||
| 02/03/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $231.86 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 264 | 384 | $190,291 | $41,297 |
| 2022 | 9 | 380 | 599 | $313,210 | $65,943 |
| 2021 | 11 | 387 | 696 | $329,906 | $82,452 |
| 2020 | 10 | 468 | 753 | $320,237 | $82,008 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 78 | 150 | $140,040 | $23,654 | 16.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 78 | $17,690 | $7,089 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 62 | 77 | $15,627 | $5,095 | 32.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $4,646 | $1,589 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,400 | $1,420 | 26.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 22 | $3,485 | $1,329 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 25 | $3,403 | $1,120 | 32.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 120 | 266 | $248,338 | $42,621 | 17.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 80 | 146 | $33,113 | $10,737 | 32.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 37 | 41 | $10,838 | $4,351 | 40.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 27 | $7,873 | $3,468 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 21 | $3,762 | $1,549 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 16 | $3,456 | $1,438 | 41.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 16 | $2,534 | $859.96 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 11 | $1,273 | $552.53 | 43.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 20 | 20 | $792.00 | $156.74 | 19.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 20 | 20 | $528.00 | $116.11 | 22.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 15 | 15 | $702.00 | $94.68 | 13.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 133 | 334 | $258,988 | $56,262 | 21.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 96 | 187 | $44,495 | $14,693 | 33.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 41 | $9,963 | $5,522 | 55.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 19 | $3,420 | $1,758 | 51.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $4,324 | $1,758 | 40.7% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 12 | 13 | $4,238 | $1,102 | 26.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 17 | $2,628 | $929.39 | 35.4% |
About Dr. Anees Afroze, M.D
Dr. Anees Afroze, M.D is a Internal Medicine healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1043352057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anees Afroze, M.D has received a total of $7,337 in payments from pharmaceutical and medical device companies, with $3,869 received in 2024. These payments were reported across 280 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,948).
As a Medicare-enrolled provider, Afroze has provided services to 1,499 Medicare beneficiaries, totaling 2,432 services with total Medicare billing of $271,701. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Springfield, MO
- Active Since 02/13/2007
- Last Updated 12/27/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043352057
Products in Payments
- Da Vinci Surgical System (Device) $3,386
- TRELEGY ELLIPTA (Drug) $343.14
- OFEV (Drug) $308.32
- Xolair (Biological) $225.27
- NUCALA (Biological) $180.46
- BREO (Drug) $177.60
- FASENRA (Drug) $155.78
- STIOLTO RESPIMAT (Drug) $154.66
- CLEVIPREX (Drug) $145.36
- AVYCAZ (Drug) $136.83
- XOLAIR (Biological) $133.98
- ANORO (Drug) $127.05
- BEVESPI AEROSPHERE (Drug) $105.04
- Arikayce (Drug) $85.49
- Prolastin-C Liquid (Biological) $80.38
- Letairis (Drug) $74.25
- OPSUMIT MACITENTAN (Drug) $69.65
- LONHALA MAGNAIR (Drug) $68.51
- FASENRA (Biological) $67.87
- OPSUMIT (Drug) $67.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372